Wholesale Western Medicine GMP Pharmaceutical Drug Beclomethasone Aerosol

 beclometasone dipropionate Aerosol  100mcg 200doses

Therapeutic indications
Adults 
Prophylactic management in: 
Mild asthma (PEF values greater than 80% predicted at baseline with less than 20% variability): Patients requiring intermittent symptomatic bronchodilator asthma medication on more than an occasional basis. 
Moderate asthma (PEF values 60-80% predicted at baseline with 20-30% variability): Patients 
requiring regular asthma medication and patients with unstable or worsening asthma on other 
prophylactic therapy or bronchodilator alone. 
Severe asthma (PEF values less than 60% predicted at baseline with greater than 30% variability): Patients with severe chronic asthma. On transfer to high dose inhaled beclometasone dipropionate, many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce significantly or eliminate their requirement for oral corticosteroids.
Paediatric population (7-12 years) 
Any child who requires prophylactic asthma medication
Dose and method of administration
Adults and children over 12 years of age 
Patients should be given a starting dose of inhaled beclometasone dipropionate (BECLAZONE 50 micrograms CFC-Free Inhaler or BECLAZONE 100 micrograms CFC-Free Inhaler or BECLAZONE 250 micrograms CFC-Free Inhaler) which is appropriate for the severity of their disease based on the following guidance: 
Mild asthma: 200 to 600mcg per day in divided doses. 
Moderate asthma: 600 to 1000mcg per day in divided doses. 
Severe asthma: Up to 1000mcg per day in divided doses. 
The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to the individual response. 
Paediatric population (7-12 years) Up to 200mcg per day in divided doses. 
Children should be given a starting dose of inhaled beclometasone dipropionate which is appropriate for the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to the individual response. There are no data on the use of Beclazone CFC-Free Inhaler in children aged under seven years.
Method of administration 
For inhalation use.

Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); Chemicals (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet requirements of Standard GMP and current BP,USP version.

We will spare no efforts to meet your demands!